ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

ASN / Education & Meetings / Kidney Week /

Please note that you are viewing an archived section from 2023 and some content may be unavailable. To unlock all content for 2023, please visit the archives.

Abstract: SA-PO589

Association of Bioimpedance Parameters with Changes in Blood Pressure During Hemodialysis: A Secondary Analysis of the Frequent Hemodialysis Network (FHN) Daily Trial

Session Information

Category: Dialysis

  • 801 Dialysis: Hemodialysis and Frequent Dialysis

Authors

  • Sayed, Enass, Brigham and Women's Hospital, Boston, Massachusetts, United States
  • Farag, Youssef MK, Bayer US, New Jersey, New Jersey, United States
  • Ravi, Katherine Scovner, Brigham and Women's Hospital, Boston, Massachusetts, United States
  • Chertow, Glenn, Stanford University School of Medicine, Stanford, California, United States
  • McCausland, Finnian R., Brigham and Women's Hospital, Boston, Massachusetts, United States
Background

Intra-dialytic hypertension (IDHyper) affects 5-15% of patients and is associated with cardiovascular and all-cause mortality. Hypervolemia is thought to be a major etiological factor, yet the association of objective measures of volume with IDHyper is not well described.

Methods

In post hoc analyses of the FHN Daily Trial (n=234), using data from baseline, 1, 4, and 12 months (n=800), random effects regression was used to assess the association of bioimpedance measures of volume and general health (vector length and phase angle) with post-HD SBP (continuous) and any increase in SBP (categorical) from pre- to post-HD. Models were adjusted for randomized group, age, sex, race, BMI, vascular access, HD vintage, hypertension, heart failure, diabetes, residual urea clearance, pre-HD SBP, hemoglobin, phosphorus, and eKt/V.

Results

Mean age was 50 ±14 years; 39% were female; 43% were Black. Shorter vector length (per 50 Ω/m) was associated with higher post-HD SBP (3.1 mmHg; 95%CI 2.0, 4.2; Fig. 1) and higher odds of IDHyper (OR 1.64; 95%CI 1.13, 2.39). The lowest tertile of vector length (vs. highest) was associated with higher post-HD SBP (6.3 mmHg; 95%CI 3.3, 9.3) and a trend toward higher odds of IDHyper (OR 2.09 95%CI 0.81, 5.35). Narrower phase angle (per 1 degree) was associated with higher post-HD SBP (1.0 mmHg; 95%CI 0.3, 1.6), and higher odds of IDHyper (OR 1.33; 95%CI 1.03, 1.72). The lowest tertile of phase angle (vs. highest) was associated with higher post-HD SBP (5.5 mmHg; 95%CI 2.6, 8.4) and higher odds of IDHyper (OR 2.74; 95%CI 1.11, 6.76).

Conclusion

Bioimpedance measures of volume status are independently associated with higher post-HD SBP and risk of IDHyper. Incorporation of bioimpedance measurement at individual HD sessions may help identify a subgroup of patients at risk of IDHyper.

Mean vector length and mean post-HD SBP

Funding

  • NIDDK Support